Induced pluripotent stem cells and Parkinson's disease: modelling and treatment

被引：14
|
作者：
Xu, Xiaoyun [1 ]
Huang, Jinsha [1 ]
Li, Jie [1 ]
Liu, Ling [1 ]
Han, Chao [1 ]
Shen, Yan [1 ]
Zhang, Guoxin [1 ]
Jiang, Haiyang [1 ]
Lin, Zhicheng [2 ]
Xiong, Nian [1 ]
Wang, Tao [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, 1277 Jiefang Rd, Wuhan 430022, Hubei, Peoples R China
[2] Harvard Univ, McLean Hosp, Mailman Neurosci Res Ctr, Dept Psychiat,Med Sch,Div Alcohol & Drug Abuse, Belmont, MA 02178 USA
来源：
CELL PROLIFERATION | 2016年 / 49卷 / 01期
基金：
中国国家自然科学基金;
关键词：
MIDBRAIN DOPAMINERGIC-NEURONS; IPSC-DERIVED NEURONS; PRIMATE MODEL; HIGHLY EFFICIENT; RAT MODEL; NEURAL PRECURSORS; OXIDATIVE STRESS; IN-VITRO; GENERATION; DIFFERENTIATION;
D O I：
10.1111/cpr.12229
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Many neurodegenerative disorders, such as Parkinson's disease (PD), are characterized by progressive neuronal loss in different regions of the central nervous system, contributing to brain dysfunction in the relevant patients. Stem cell therapy holds great promise for PD patients, including with foetal ventral mesencephalic cells, human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). Moreover, stem cells can be used to model neurodegenerative diseases in order to screen potential medication and explore their mechanisms of disease. However, related ethical issues, immunological rejection and lack of canonical grafting protocols limit common clinical use of stem cells. iPSCs, derived from reprogrammed somatic cells, provide new hope for cell replacement therapy. In this review, recent development in stem cell treatment for PD, using hiPSCs, as well as the potential value of hiPSCs in modelling for PD, have been summarized for application of iPSCs technology to clinical translation for PD treatment.
引用
收藏
页码：14 / 26
页数：13
相关论文
共 50 条
  • [21] Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
    Mária Cs?b?nyeiová
    ?ubo? Dani?ovi?
    ?tefan Polák
    Neural Regeneration Research, 2016, 11 (05) : 727 - 728
  • [22] Parkinson's disease: An update on preclinical studies of induced pluripotent stem cells
    Valadez-Barba, V.
    Juarez-Navarro, K.
    Padilla-Camberos, E.
    Diaz, N. F.
    Guerra-Mora, J. R.
    Diaz-Martinez, N. E.
    NEUROLOGIA, 2023, 38 (09): : 681 - 694
  • [23] Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
    Csobonyeiova, Maria
    Danisovic, Lubos
    Polak, Stefan
    NEURAL REGENERATION RESEARCH, 2016, 11 (05) : 727 - 728
  • [24] Solving the puzzle of Parkinson's disease using induced pluripotent stem cells
    Zhao, Ping
    Luo, Zhiwei
    Tian, Weihua
    Yang, Jiayin
    Ibanez, David P.
    Huang, Zhijian
    Tortorella, Micky D.
    Esteban, Miguel A.
    Fan, Wenxia
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 239 (11) : 1421 - 1432
  • [25] Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
    Devine, Michael J.
    Ryten, Mina
    Vodicka, Petr
    Thomson, Alison J.
    Burdon, Tom
    Houlden, Henry
    Cavaleri, Fatima
    Nagano, Masumi
    Drummond, Nicola J.
    Taanman, Jan-Willem
    Schapira, Anthony H.
    Gwinn, Katrina
    Hardy, John
    Lewis, Patrick A.
    Kunath, Tilo
    NATURE COMMUNICATIONS, 2011, 2
  • [26] Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells
    Jiali Pu
    Houbo Jiang
    Baorong Zhang
    Jian Feng
    Current Neurology and Neuroscience Reports, 2012, 12 : 392 - 398
  • [27] Induced Pluripotent Stem Cells in Disease Modelling and Regeneration
    Talug, Burcu
    Tokcaer-Keskin, Zeynep
    CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 5, STEM CELLS: TRANSLATIONAL SCIENCE TO THERAPY, 2019, 1144 : 91 - 99
  • [28] Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
    Helen A. Rowland
    Nigel M. Hooper
    Katherine A. B. Kellett
    Neurochemical Research, 2018, 43 : 2179 - 2198
  • [29] Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells
    Rowland, Helen A.
    Hooper, Nigel M.
    Kellett, Katherine A. B.
    NEUROCHEMICAL RESEARCH, 2018, 43 (12) : 2179 - 2198
  • [30] Opportunities and Limitations of Modelling Alzheimer's Disease with Induced Pluripotent Stem Cells
    Ovchinnikov, Dmitry A.
    Wolvetang, Ernst J.
    JOURNAL OF CLINICAL MEDICINE, 2014, 3 (04): : 1357 - 1372
12345